Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-25

Clinical Trial Update: Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating skin irritation and/or sensitization potential of an antifungal cream containing trolamine; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • antifungal cream containing trolamine (trolamine-containing antifungal cream)

Snippet

Sponsor: Bayer | Conditions: Hypersensitivity | Phase 3 | Status: COMPLETED | Results posted: 2020-09-25